Maintain current weight. Do not exceed S&P weight until the multiple compresses meaningfully or the legal overhang resolves. Trim into $957-970 resistance if reached. Wait for confirmed pullback to $905-920 with actual RSI divergence before considering any adds.

• 41x forward P/E with 4.66 PEG ratio is a risk variable, not a fixed input — requires flawless execution to defend
• May-to-July drawdown from $1,094 to $905 (17% peak-to-trough) in a defensive name with 0.86 beta demonstrates multiple compression risk
• MACD histogram at -0.89 is not bullish divergence — momentum is actively bleeding, not coiled for a squeeze
• RSI at 44 is not capitulation exhaustion; prior lows had RSI in the 33-35 range, meaning both price and momentum are making lower lows simultaneously
• Tariff class action: plaintiffs' counsel noted the defendant's primary legal argument had 'evaporated,' signaling asymmetric legal exposure beyond the $300M settlement range cited
• SCAN Medicare partnership is a small proof-of-concept with significant execution risk — projecting a 2030 outcome onto a 2026 announcement is speculation
• AI search conversion is a data point, not a thesis; high conversion on small volume is not a re-rating catalyst
• Higher-for-longer Fed regime does not protect Costco from sector de-rating — Walmart beat and raised guidance yet dropped 10-12% as market repriced consumer defensive complex
• Adding aggressively at $920 with stop at $895 creates 3-4% position-level loss on a stock with rich entry valuation

→ vs aggressive: The 26.5x forward P/E premium is treated as a fixed input rather than a risk variable; a 41x multiple requires flawless execution and compresses fast on any narrative wobble

→ vs aggressive: MACD histogram at -0.89 is being read backwards as bullish — compressed volatility in a downtrend resolves down more often than up

→ vs aggressive: The $300M tariff settlement range is treated as a ceiling when plaintiffs' counsel stated the primary legal argument had 'evaporated,' signaling asymmetric exposure beyond comparable cases

→ vs aggressive: SCAN Medicare is described as 'high-margin, sticky recurring revenue' with no operational details released — projecting 2030 outcomes onto a 2026 announcement is speculation

→ vs aggressive: AI search conversion rate is high conversion on small volume; tells nothing about absolute scale of digital business and is not a re-rating catalyst

→ vs aggressive: The 'no Fed cuts = defensive floor' argument contradicts recent sector tape; Walmart beat and raised guidance but dropped 10-12% as market repriced consumer defensive for slower growth

→ vs aggressive: The 'add on weakness, trim on strength' framework is discretionary tactical trading with execution slippage and timing risk, not conservative risk management

HOLD with phased scaling: add 10-15% of target on confirmation at $945.44 with volume, trim 15-20% into $957-970, maintain $895 stop

• COST at $934.66 represents 1.6% unrealized gain from $920 entry; risk is giving back ~4% before stop triggers, not giving back meaningful gains
• RSI 44 is not capitulation exhaustion—prior wash-outs occurred at RSI 33-35 with price at swing lows; current setup likely to make fresh low with RSI in 30s
• Base rate favors downside resolution for stocks below three moving averages with bearish MACD and intact lower-high pattern
• Tariff class action (~300M cap, 0.07% of market cap) creates binary event risk around Q4 earnings in late September but is manageable given $414B market cap and $13.3B net cash
• SCAN Medicare partnership is proof-of-concept strategic optionality, not near-term catalyst—belongs in thesis narrative, not multiple
• Jackson Hole creates three sequential judgment calls regardless of outcome; pre-commitment to specific actions required
• S&P weight cap limits position-level risk; diversification already addressed
• Only add if COST bounces from current levels AND reclaims $945.44 on volume above 2.5M shares—do not add on Bollinger band breach below $933.39
• Q4 earnings print is more meaningful fundamental catalyst than Jackson Hole; trim modestly to maintain exposure into print
• Conservative analyst's capital preservation framing overstates risk given existing 1.6% gain; stop at $895 below July swing low provides adequate protection

→ vs aggressive: Coiled spring metaphor is analytically lazy—compressed volatility has no directional bias and historically resolves down more often for stocks in this technical configuration

→ vs aggressive: Adding full third of target at $920 on RSI divergence is too aggressive; 10-15% confirmation-based add is appropriate, not pre-emptive

→ vs aggressive: Jackson Hole 'volatility monetization' framing understates execution complexity—three sequential judgment calls in sequence creates timing risk

→ vs conservative: 'Preserve capital' framing assumes position is underwater; at $934.66 vs $920 entry, position is in profit and risk is bounded

→ vs conservative: Waiting for legal overhang to resolve before any adds is market-timing—confirmation-based approach with defined triggers is better framework

→ vs conservative: SCAN partnership dismissal misses strategic optionality signal; belongs in thesis narrative even if not in near-term multiple

→ vs conservative: 'Don't trim anything' is wrong—take modest profit into resistance when offered; Q4 print is catalyst, but so is $957-970 zone